ARCH Venture Partners invests in early‑stage life‑science companies developing breakthrough scientific discoveries to prevent, detect, and cure disease. They provide flexible capital ranging from as low as $50 k up to hundreds of millions, taking a contrarian, long‑term approach and partnering closely with founder teams.
Industries
Industry breakdown
Top industries in the portfolio
Geography
Geographic scope
United States
Geography breakdown
Darker regions = more portfolio companies
Top 5 countries
United States of America
65.3%United Kingdom
13.7%People's Republic of China
3.2%Australia
1.6%Canada
0.8%Other
4.0%Countries with a higher share of the portfolio are shaded darker on the map.
Stages
Stage indicator
Pre-Seed → Series A
Stage breakdown
Portfolio by stage
Portfolio vintage
Companies by founded year
Fund details
Funds
Fund XII
Vintage 2022 • $3B
Fund XIII
Vintage 2024 • $3B
Check sizes
Min: $50K